Kazuma Sugimoto

Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma

H. Kume, M. Kinjo, Kazuki Masuda, 2022, BMC Urology.

Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function

T. Kenzaka, H. Akita, Ken Goda, 2021, Medicine.

Encephalopathy Induced by Preventive Administration of Acyclovir in a Man with Symptomatic Multiple Myeloma and Renal Dysfunction

T. Kenzaka, A. Kitao, Ryusiro Sugimoto, 2021, International journal of general medicine.

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.

H. Nishimatsu, H. Kume, D. Obinata, 2023, Immunotherapy.

Enfortumab vedotin versus platinum rechallenge in post‐platinum, post‐pembrolizumab advanced urothelial carcinoma: A multicenter propensity score‐matched study

H. Nishimatsu, H. Kume, D. Obinata, 2023, International journal of urology : official journal of the Japanese Urological Association.